Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Net Cash Flow (2018 - 2025)

Historic Net Cash Flow for Neurogene (NGNE) over the last 6 years, with Q3 2025 value amounting to $12.2 million.

  • Neurogene's Net Cash Flow rose 12746.01% to $12.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.4 million, marking a year-over-year decrease of 7962.63%. This contributed to the annual value of -$11.8 million for FY2024, which is 11768.15% down from last year.
  • Latest data reveals that Neurogene reported Net Cash Flow of $12.2 million as of Q3 2025, which was up 12746.01% from -$11.9 million recorded in Q2 2025.
  • Neurogene's 5-year Net Cash Flow high stood at $103.2 million for Q4 2023, and its period low was -$65.8 million during Q1 2025.
  • Moreover, its 3-year median value for Net Cash Flow was -$11.9 million (2025), whereas its average is -$970636.4.
  • Within the past 5 years, the most significant YoY rise in Neurogene's Net Cash Flow was 12746.01% (2025), while the steepest drop was 394810.05% (2025).
  • Quarter analysis of 3 years shows Neurogene's Net Cash Flow stood at $103.2 million in 2023, then plummeted by 32.22% to $70.0 million in 2024, then plummeted by 82.57% to $12.2 million in 2025.
  • Its last three reported values are $12.2 million in Q3 2025, -$11.9 million for Q2 2025, and -$65.8 million during Q1 2025.